ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics Inc (QB) (NWBO)

0.2974
-0.0146
( -4.68% )
Updated: 12:49:59

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.2974
Bid
0.2852
Ask
0.2974
Volume
2,525,690
0.285 Day's Range 0.324
0.242 52 Week Range 0.65
Market Cap
Previous Close
0.312
Open
0.3063
Last Trade
25000
@
0.2974
Last Trade Time
12:49:55
Financial Volume
$ 772,914
VWAP
0.306021
Average Volume (3m)
2,738,073
Shares Outstanding
1,297,445,623
Dividend Yield
-
PE Ratio
-3.43
Earnings Per Share (EPS)
-0.05
Revenue
1.93M
Net Profit
-64.37M

About Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is i... Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Northwest Biotherapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NWBO. The last closing price for Northwest Biotherapeutics (QB) was $0.31. Over the last year, Northwest Biotherapeutics (QB) shares have traded in a share price range of $ 0.242 to $ 0.65.

Northwest Biotherapeutics (QB) currently has 1,297,445,623 shares outstanding. The market capitalization of Northwest Biotherapeutics (QB) is $404.80 million. Northwest Biotherapeutics (QB) has a price to earnings ratio (PE ratio) of -3.43.

NWBO Latest News

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

Both Shuttle Pharmaceuticals (Nasdaq:SHPH) and Northwest Biotherapeutics

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.030411.38576779030.2670.3580.2649547308660.29818192CS
40.02649.741697416970.2710.3580.25224531821590.28057832CS
120.02639.7012172630.27110.3580.24227380730.27705878CS
26-0.0846-22.14659685860.3820.40.24225035220.29981688CS
52-0.3225-52.02452008390.61990.650.24221080740.37920503CS
156-0.5052-62.94542736110.80262.050.24221680420.65672698CS
2600.100450.96446700510.1972.540.00524624660.82378605CS

NWBO - Frequently Asked Questions (FAQ)

What is the current Northwest Biotherapeutics (QB) share price?
The current share price of Northwest Biotherapeutics (QB) is $ 0.2974
How many Northwest Biotherapeutics (QB) shares are in issue?
Northwest Biotherapeutics (QB) has 1,297,445,623 shares in issue
What is the market cap of Northwest Biotherapeutics (QB)?
The market capitalisation of Northwest Biotherapeutics (QB) is USD 404.8M
What is the 1 year trading range for Northwest Biotherapeutics (QB) share price?
Northwest Biotherapeutics (QB) has traded in the range of $ 0.242 to $ 0.65 during the past year
What is the PE ratio of Northwest Biotherapeutics (QB)?
The price to earnings ratio of Northwest Biotherapeutics (QB) is -3.43
What is the cash to sales ratio of Northwest Biotherapeutics (QB)?
The cash to sales ratio of Northwest Biotherapeutics (QB) is 113.33
What is the reporting currency for Northwest Biotherapeutics (QB)?
Northwest Biotherapeutics (QB) reports financial results in USD
What is the latest annual turnover for Northwest Biotherapeutics (QB)?
The latest annual turnover of Northwest Biotherapeutics (QB) is USD 1.93M
What is the latest annual profit for Northwest Biotherapeutics (QB)?
The latest annual profit of Northwest Biotherapeutics (QB) is USD -64.37M
What is the registered address of Northwest Biotherapeutics (QB)?
The registered address for Northwest Biotherapeutics (QB) is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
Which industry sector does Northwest Biotherapeutics (QB) operate in?
Northwest Biotherapeutics (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc (CE)
$ 0.008
(799,900.00%)
400
TMPOQTempo Automation Holdings Inc (CE)
$ 0.0009
(89,900.00%)
100
PKLBFPerk Labs Inc (CE)
$ 0.0003
(29,900.00%)
50k
FUVVArcimoto Inc (CE)
$ 0.0002
(19,900.00%)
628
FBCDFBC Holding Inc (PK)
$ 0.0001
(9,900.00%)
3k
HOMUHoumu Holdings Ltd (CE)
$ 0.000001
(-99.95%)
148
SHMPNaturalShrimp Incorporated (CE)
$ 0.000001
(-99.75%)
1.4M
BWVIBlue Water Ventures International Inc (CE)
$ 0.000001
(-99.75%)
117
SDCCQSmileDirectClub Inc (CE)
$ 0.000001
(-99.75%)
74.05k
GENNGenesis Healthcare Inc (CE)
$ 0.000001
(-99.50%)
3.06k
TKMOTekumo Inc (PK)
$ 0.0003
(20.00%)
400.05M
PHILPHI Group Inc (PK)
$ 0.00025
(25.00%)
288.43M
HMBLHUMBL Inc (PK)
$ 0.0007
(-12.50%)
139.84M
HCMCHealthier Choices Management Corporation (PK)
$ 0.000001
(-98.00%)
113.35M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.0032
(-4.48%)
69.45M

NWBO Discussion

View Posts
Investor082 Investor082 52 seconds ago
It won’t matter without reimbursement support anyway. There are only so many people that can pay out of pocket. Gofundme is not a solution for a company that’s serious about commercialization.

Specials revenue is a good indicator of what’s coming post approval. At best, they get 5X to 10X of that in the first year. Even that will be a stretch without some sort of support from CDF.
👍️0
martyDg martyDg 4 minutes ago
It’s useless to argue with these people who think revenue will skyrocket in the first year or even the next 5 years after approval. They never learn from the special revenue. Oh well, they're here to hype things up, not be conservative. They're here to excite bagholders into buying more shares or keeping them invested.
💯 1
learningcurve2020 learningcurve2020 4 minutes ago
That’s for sure. LP always steps in it.

>>with the explosive growth in retail trading in recent years.
👍️0
learningcurve2020 learningcurve2020 8 minutes ago
What if Advent handles everything in a hypothetical approval?
👍️0
exwannabe exwannabe 10 minutes ago
From some other stats, it is mainly OTC that is driving the growth, not black pools and such.

See https://www.nyse.com/data-insights/market-volume-and-off-exchange-trading

Not surprising that penny stocks trade on OTC and their trade volume has bee growing with the explosive growth in retail trading in recent years.

But if OTC is such a bad thing and explains what is wrong why the world, why invest in a stock that elected to no longer trade on a National Exchange and prefer the darkness of the OTC?
👍️0
Investor082 Investor082 12 minutes ago
I agree. They don’t have the team to even manage $5M in annual revenue. When will hiring start to support increase in revenue going from $1.5M in Specials revenue to say even $10M? LP does not believe they have a shot at meaningful revenue uptick in the first year without reimbursement support. Otherwise she would have started hiring a while back.
👍️0
martyDg martyDg 12 minutes ago
No you're just gullible to think that yesterday was different from the rest of the pump. idiot
👍️0
norisknorewards norisknorewards 15 minutes ago
interesting day, especially after that gap was closed. if i were to guess, i bet the stock has a little surge shortly given the possible MTD (tonight??) and of course a pending MAA

we shall see
👍️0
exwannabe exwannabe 17 minutes ago
I would bet on under $10M in calendar 2025. And if forced to bet on over/under $5M, I would go under.
👍️0
Investor082 Investor082 20 minutes ago
LOL, i will put you on a reminder list along with Doc Logic every quarter as NWBO reports revenues from UK. Your buddy Doc Logic says $90M for the first year. Is yours higher than $90M in the first year?

I say less than $15M in the first year.

Let’s monitor every quarter and see who is BSing. No excuses permitted!
👍️0
learningcurve2020 learningcurve2020 26 minutes ago
“And there have always been and there always will be the same percentage of winners and losers, happy fuckers and sad suckers, fat cats and starving dogs in this world. Yeah, there may be more of us today than there's ever been, but the percentages—they stay exactly the same.”

-John Tuld
👍️0
learningcurve2020 learningcurve2020 35 minutes ago
The only thing JAMA appears to have been good for is extending retail shareholders patience. Hmm.
👿 1 💀 1
CaptainObvious CaptainObvious 35 minutes ago
I'm losing faith in the whole 'Stocks represent ownership' concept.
👍️ 2 😂 1
LTR LTR 38 minutes ago
So I am reading the article you attached that states for 5 months running now, more trades are made off exchange than on exchanges and why thats concerning. I wasn't totally understanding until they said off exchange trades are handled by firms like Citadel and Virtue. Light bulb! Now I fully understand the "concern". That is more than half of all trades ?!?!! Something needs to change big, and soon. Our "free" markets are really a joke and a scam.
👍️ 9 😠 1
martyDg martyDg 41 minutes ago
So JAMA publication was wrong since it's only a few months of extension not 10-30 years oh I'm sorry. I guess you're the expert. And I should invalidate the JAMA over your statement.
👿 1 💀 1
learningcurve2020 learningcurve2020 48 minutes ago
🤷‍♀️

What this stock needs is another ass kicking-lumberjack looking-Gen X’r to get the ball rolling! Maybe put him on the BigBiz Show??
👗 1 👙 1 👿 1 💀 1
XMaster2023 XMaster2023 51 minutes ago
Your correct. Unfortunately, we can only extend life. 10 - 30 years but it’s only an extension.
👍️ 1
CaptainObvious CaptainObvious 1 hour ago
https://finance.yahoo.com/news/wall-street-enters-darker-age-110003632.html
👍️ 4
manibiotech manibiotech 1 hour ago
Great explanation
Thanks 
👍️0
Ready4Nxt Ready4Nxt 1 hour ago
Strange listing for CDEL on Level 2 "ask" - .4116, way over it's normal range.
👍️0
attilathehunt attilathehunt 1 hour ago
I thought they were so scared that they are trying to settle asap

I guess you don't know how attorney fees work.
👍️ 2
martyDg martyDg 1 hour ago
You mean to extend, not to cure, right? LOL
👿 1 💀 1 🚽 1
martyDg martyDg 1 hour ago
You mean to extend, not to cure, right? LOL
👿 1 💀 1
martyDg martyDg 1 hour ago
And you expect an influx of patients wanting the vaccine with a high price tag? Good luck with that. DCVax is not like a mass-produced product that can be rolled out to the entire world within the span of a year. They can't even maximize today's capacity. And even with many patients wanting the vaccine, I highly doubt that LP can accommodate them all. The way she runs and processes everything, it will take years to expand. Even with Flashworks. Doubt that shit.
👿 1 💀 1
Gus1212 Gus1212 1 hour ago
Thanks flip
I had a couple of nickles left
I played your post just about the gap and picked up another 10,000 shares.




Don't make Me Leak!
👍️ 5 🤣 1
manibiotech manibiotech 2 hours ago
Sure Freefrad 
👿 1 💀 1
Reefrad Reefrad 2 hours ago
There was no pump idiot. There is however trashing and shorting by you and your nasty brethren.
👍️ 4 🤣 1
XMaster2023 XMaster2023 2 hours ago
“Many idiots doesn't have common sense”
So true MartyDg. Some idiots can’t even string together a sentence. But the market makers hire them because you need to be an idiot to bash the next step in curing cancer.
👍️ 7 😄 4 🤧 1
manibiotech manibiotech 2 hours ago
lol

👿 1 💀 1
manibiotech manibiotech 2 hours ago
Can you provide a link to contract with Advent . What percentage of that revenue will go to Advent ? Can you provide breakdown of revenue from patients treated under specials ? 
👿 1 💀 1
XMaster2023 XMaster2023 2 hours ago
330 patients is about 1 billion in market cap. You’re way off in your revenue projections.
More importantly, it’s the value of the platform for all cancer. Those numbers are definitely in the trillions and are mind boggling.
On top of that, each BP with a checkpoint inhibitor will need to play. Now. They are waiting patiently for approval. Then all shit will hit the fan. All IMO.
👍️ 2 🤑 1
bas2020 bas2020 2 hours ago
Now that your bosses have closed the gap, the path upward is clear.
Bought 50k more (sub .29)! Thanks!
🎯 2 🏆️ 3 👍️ 3 😂 1 🤣 1
martyDg martyDg 2 hours ago
Damn, My .355 sell order didn't get fill. sucks! Buy at .24-.25 again and sell at .28-.35. Rinse and repeat. That's the only way you can milk this stock. If you wait for the good news then I'm sorry but the crow has more chances to turned white than to get a news here.
👿 1 💀 1
flipper44 flipper44 2 hours ago
Not what I meant. Remind me not to fly in any of your planes.
👍️0
martyDg martyDg 2 hours ago
Many idiots doesn't have common sense. They always talk about the approval, was yesterday pump due to approval? Exactly! No.
👗 1 👿 1 💀 2 🚽 1 ⛔️ 1
norisknorewards norisknorewards 2 hours ago
Lol, gap closed
👍️0
StonkMaster StonkMaster 2 hours ago
Gap closed.... lol :(
👍️0
Investor082 Investor082 2 hours ago
Agreed, approval is not. That’s why I believe we will have a spike (hopefully close to 100%). But what follows will be disappointing enough that the valuation will continue to drop quickly and not recover. On the other hand, dilution will add to that misery.
👗 1 👿 1 💀 1 🩱 1
manibiotech manibiotech 2 hours ago
Yesterday's increase was not because of approval , unless I missed the news .
It was just like previous half day pumps . 
👍️ 1 👙 1 👿 1 💀 2 🚫 1 🚽 2 🪠 1
XMaster2023 XMaster2023 2 hours ago
Approval is not a pump it is a binary event. As a paid basher you know this, but your trying to mislead the retail.
👍️ 4 🚀 2
XMaster2023 XMaster2023 2 hours ago
Na that’s your boss playing games with the retail newbie mind. They won’t be able to do that after approval as the institutional investors do the math and know, better than I what NWBO is worth after approval. One day soon the stock will gap up and they will not be able to afford as many shares. IMO.
👍️ 2
Investor082 Investor082 2 hours ago
Agree. It’s a classic pump and dump stock. This pattern has repeated on so many occasions over the years, never fails.
👿 1 💀 2 🚽 1
RobotDroid RobotDroid 2 hours ago
As I predicted, red today, tomorrow, and many morrows after. No news, no leak, just inept mute nonmanagement led by the supreme Grifter. Fools and their money are soon parted.
👍️ 2 👿 1 💀 1
manibiotech manibiotech 2 hours ago
Yep . There is a tussle going on . But if volume keeps drying , it will be below .30 again as usual 
👍️ 2 👿 1 💀 1 💯 1
iclight iclight 2 hours ago
Did the leaked news unleak?
👙 1 👚 1 👿 1 💀 1 🚽 1
martyDg martyDg 2 hours ago
It’s trying to close gap at .2875? Touch and go?

Touch and go down further? Sure, that's most likely what's going to happen.
👿 1 💀 1 🚽 1
iclight iclight 2 hours ago
Already approved in Switzerland from what LP said.
👿 1 💀 1
martyDg martyDg 2 hours ago
You're here for the longest time, so you should already know the pattern. Gap to close? LOL, it's just the stock doing its normal pump-and-dump routine. That's it. Would you be surprised if you see it come back to $0.25? No. I'd be more surprised if it goes higher, but the chances are slim.
👍️ 1 👿 1 💀 2 🚽 1
manibiotech manibiotech 2 hours ago
As I said - rally , momentum, volume have all stopped .
As usual half day momentum and then gone . 
👍️ 1 👿 1 💀 1
Hopeforthefuture3 Hopeforthefuture3 2 hours ago
Manibiotech will have to see if 30 cents now becomes support
Rest of market is having a great January
👍️ 1 👿 1 💀 1

Your Recent History

Delayed Upgrade Clock